Availability Of
- Unlicensed medicines
- Shortages
- Specials
- Orphan Drugs
- Named Patient Programme
- Unregistered drugs
- Generics
- Biosimilars
Affordability Due To
- Market penetration strategy, high volumes, lower pricing by MNCs in India
- Generics from WHO-GMP/PICs certified units
- Direct sourcing from company authorized channels
Accreditation By
- WHO GDP (SGS)
- ISO 9001:2015
- MOH India-CDSCO
- DGFT for licensed exports
- Ministry of Defence, India as Approved Supplier
3*Advantage For
- Healthcare professionals
- Caregivers
- Pharmacists
- Patients Groups
- Specialty pharma Importers
- Hospitals
- Patients
- NGOs